Výsledky vyhledávání

Akademický článek

Chlamydia pneumoniae-associated pleuropericarditis: a case report and systematic review of the literature

Autor: Konstantinos G. Kyriakoulis, Anastasios Kollias, George E. Diakos, Ioannis P. Trontzas, Eleni Fyta, Nikolaos K. Syrigos, Garyphallia Poulakou

Publikováno v: BMC Pulmonary Medicine, Vol 21, Iss 1, Pp 1-8 (2021)

Abstract Background Chlamydia pneumoniae is a common cause of atypical community acquired pneumonia (CAP). The diagnostic approach of chlamydial infections remains a challenge. Diagnosis of delayed chlamydial-associated complications, involving compl

Externí odkaz: https://doaj.org/article/af2644c69b104dd8acd9ba701ad7d215

Zobrazit plný text záznamu

Akademický článek

Programmed Cell Death Protein 1 Axis Inhibition in Viral Infections: Clinical Data and Therapeutic Opportunities

Autor: Konstantinos Tsiakos, Niki Gavrielatou, Ioannis A. Vathiotis, Loukas Chatzis, Stamatios Chatzis, Garyfallia Poulakou, Elias Kotteas, Nikolaos K. Syrigos

Publikováno v: Vaccines, Vol 10, Iss 10, p 1673 (2022)

A vital function of the immune system is the modulation of an evolving immune response. It is responsible for guarding against a wide variety of pathogens as well as the establishment of memory responses to some future hostile encounters. Simultaneou

Externí odkaz: https://doaj.org/article/2322d9ee04db477095d85347aaf2e075

Zobrazit plný text záznamu

Akademický článek

Greek Remdesivir Cohort (GREC) Study: Effectiveness of Antiviral Drug Remdesivir in Hospitalized Patients with COVID-19 Pneumonia

Autor: Vasilis Petrakis, Vasiliki Rapti, Karolina Akinosoglou, Constantinos Bonelis, Kalomoira Athanasiou, Vasiliki Dimakopoulou, Nikolaos K. Syrigos, Nikolaos Spernovasilis, Grigoris Trypsianis, Markos Marangos, Charalambos Gogos, Dimitrios Papazoglou, Periklis Panagopoulos, Garyfallia Poulakou

Publikováno v: Microorganisms, Vol 10, Iss 10, p 1949 (2022)

In several randomized studies, remdesivir (RDV) has been reported to shorten the recovery period and improve clinical outcomes in COVID-19 patients, and thus, it is recommended as a standard of care. Nevertheless, controversial reports have been publ

Externí odkaz: https://doaj.org/article/dc57e712b5e14c8ba7e4e29aa288743f

Zobrazit plný text záznamu

Akademický článek

New Insights into SARS-CoV-2 and Cancer Cross-Talk: Does a Novel Oncogenesis Driver Emerge?

Autor: Vasiliki Rapti, Thomas Tsaganos, Ioannis A. Vathiotis, Nikolaos K. Syrigos, Peifeng Li, Garyfallia Poulakou

Publikováno v: Vaccines, Vol 10, Iss 10, p 1607 (2022)

Since the pandemic’s onset, a growing population of individuals has recovered from SARS-CoV-2 infection and its long-term effects in some of the convalescents are gradually being reported. Although the precise etiopathogenesis of post-acute COVID-1

Externí odkaz: https://doaj.org/article/badf69c4e93d426ba0249d3590a11468

Zobrazit plný text záznamu

Akademický článek

Tinzaparin Safety in Patients With Cancer and Renal Impairment: A Systematic Review

Autor: I. A. Vathiotis MD, PhD, N. K. Syrigos MD, PhD, E. P. Dimakakos MD, PhD

Publikováno v: Clinical and Applied Thrombosis/Hemostasis, Vol 27 (2021)

Low-molecular-weight heparins are approved for primary and secondary venous thromboembolism prevention. Tinzaparin is the low-molecular-weight heparin with the highest average molecular weight. The purpose of this systematic review is to provide an u

Externí odkaz: https://doaj.org/article/9f6339293770478fb6ae8f6531f20262

Zobrazit plný text záznamu